MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-01-31, VNOV has $2,311,806 in assets. $457,975 in debts.

Balance Sheets Overview

Current Ratio
504.79%
Quick Ratio
476.31%
Debt to Asset Ratio
19.81%
Unit: Dollar
Assets Breakdown
    • Cash
    • Accounts receivable
    • Inventories
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Retained earnings
    • Income tax payable
    • Others

Unit: Dollar
Balance Sheets
2026-01-31
Cash
1,168,904
Accounts receivable
1,004,442
Advances to vendors
0
Inventories
130,436
Other current assets
8,024
Total current assets
2,311,806
Total assets
2,311,806
Accounts payable
108,978
Accrued expenses and other current liabilities
81,951
Income tax payable
267,046
Total current liabilities
457,975
Total liabilities
457,975
Common stock, 0.001 par value 200,000,000 shares authorized 8,337,454 shares issued and outstanding
8,337
Additional paid-in capital
1,029,646
Shares to be issued 20,000 shares of common stock
3,000
Retained earnings
812,848
Total shareholders equity
1,853,831
Total liabilities and shareholders equity
2,311,806
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$1,168,904 Accounts receivable$1,004,442 Inventories$130,436 Other current assets$8,024 Total current assets$2,311,806 Total assets$2,311,806 Total liabilities andshareholders equity$2,311,806 Total shareholdersequity$1,853,831 Total liabilities$457,975 Additional paid-in capital$1,029,646 Retained earnings$812,848 Common stock, 0.001 parvalue 200,000,000...$8,337 Shares to be issued 20,000 shares of common...$3,000 Total currentliabilities$457,975 Income tax payable$267,046 Accounts payable$108,978 Accrued expenses andother current...$81,951

VitaNova Life Sciences Corp (VNOV)

VitaNova Life Sciences Corp (VNOV)